| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |